This inventor holds 1 USPTO granted patent. Top assignees: Irbm S.p.a., Istituto Nazionale Di Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 56 
Years Active: 2025
Title: Davide Gornati: Innovator in Hepatitis B Research
Introduction
Davide Gornati is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical research, particularly in the development of inhibitors for the Hepatitis B virus. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Latest Patents
Gornati holds a patent for "Oxalamido-Substituted Tricyclic Inhibitors of Hepatitis B Virus." This patent represents a crucial advancement in the fight against Hepatitis B, showcasing his expertise and dedication to improving health outcomes.
Career Highlights
Throughout his career, Davide Gornati has worked with esteemed institutions such as Ospedale San Raffaele S.r.l. and Istituto Nazionale di Genetica Molecolare (INGM). His experiences in these organizations have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Matteo Iannacone and Leda Ivanova Bencheva. Their collaborative efforts have further enhanced the impact of Gornati's research and innovations.
Conclusion
Davide Gornati's contributions to medical research, particularly in the area of Hepatitis B, highlight his role as an influential inventor. His patent and collaborations reflect a commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile